PenderFund Capital Management’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

PenderFund Capital Management’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-96,790	Closed	-$391K	–	154
2023 Q3	$391K	Buy	+96,790	New	+$226K	0.12%	89

PenderFund Capital Management's TMBR Position: Q4 2023 in Review

PenderFund Capital Management sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 96,790 shares — an estimated $391K sold.

PenderFund Capital Management first reported a position in TMBR in Q3 2023 and held it in 1 quarter. The position peaked at $391K in Q3 2023. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.

PenderFund Capital Management reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
PenderFund Capital Management sold 96,790 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $391K.
PenderFund Capital Management first reported a position in Timber Pharmaceuticals, Inc. in Q3 2023 and held it in 1 quarter.
PenderFund Capital Management's Timber Pharmaceuticals, Inc. position peaked at $391K in Q3 2023.
0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.

Based on PenderFund Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.